Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Capital Leases (2016 - 2024)

iBio (IBIO) has disclosed Capital Leases for 9 consecutive years, with $53000.0 as the latest value for Q2 2024.

  • Quarterly Capital Leases fell 84.9% to $53000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $53000.0 through Jun 2024, down 84.9% year-over-year, with the annual reading at $53000.0 for FY2024, 84.9% down from the prior year.
  • Capital Leases for Q2 2024 was $53000.0 at iBio, down from $130000.0 in the prior quarter.
  • The five-year high for Capital Leases was $32.0 million in Q2 2020, with the low at $30000.0 in Q2 2022.
  • Average Capital Leases over 5 years is $11.4 million, with a median of $422000.0 recorded in 2023.
  • The sharpest move saw Capital Leases plummeted 99.91% in 2022, then skyrocketed 1070.0% in 2023.
  • Over 5 years, Capital Leases stood at $31.8 million in 2020, then tumbled by 99.84% to $51000.0 in 2021, then surged by 860.78% to $490000.0 in 2022, then plummeted by 58.16% to $205000.0 in 2023, then crashed by 74.15% to $53000.0 in 2024.
  • According to Business Quant data, Capital Leases over the past three periods came in at $53000.0, $130000.0, and $205000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.